Eton Pharmaceuticals: An Undervalued Small Cap With High Growth [Seeking Alpha]
Eton Pharmaceuticals, Inc. (ETON)
Last eton pharmaceuticals, inc. earnings: 3/5 04:02 pm
Check Earnings Report
Company Research
Source: Seeking Alpha
My DCF-based Fair Value is $28.1, representing 85% upside; optimistic scenarios suggest up to $40 per share, while downside risk is mitigated by product diversification. Revenue growth, free cash flow positivity, and declining SG&A margins support a Buy-to-Strong Buy stance at $15.17, despite high uncertainty from US drug pricing. My strategy favors incremental share accumulation, with position sizing responsive to technical signals, product launches, and evolving Fair Value estimates. nambitomo/iStock via Getty Images Article Thesis I wrote about ETON Pharmaceuticals ( ETON ) at the beginning of August. I liked this company (and still do) because: They acquire ultra-rare disease drugs (aided by some internal development) at very low prices, and these are This article was written by Analyst's Disclosure: I/we have a beneficial long position in the shares of ETON either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresse
Show less
Read more
Impact Snapshot
Event Time:
ETON
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ETON alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ETON alerts
High impacting Eton Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ETON
News
- Eton Pharmaceuticals Announces Licensing of Rare Disease Product Candidate [Yahoo! Finance]Yahoo! Finance
- Eton Pharmaceuticals Announces Licensing of Rare Disease Product CandidateGlobeNewswire
- Eton Pharmaceuticals (NASDAQ:ETON) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.MarketBeat
- Those who invested in Eton Pharmaceuticals (NASDAQ:ETON) three years ago are up 483% [Yahoo! Finance]Yahoo! Finance
- Eton Pharmaceuticals to Present at Piper Sandler 37th Annual Healthcare Conference on December 4thGlobeNewswire
ETON
Earnings
- 11/6/25 - Miss
ETON
Sec Filings
- 2/5/26 - Form 4
- 2/2/26 - Form 8-K
- 1/14/26 - Form 4
- ETON's page on the SEC website